Upon entry into the nucleus, cGAS interacts with PARP1 and inhibits the formation of PARP1-Timeless complex, thereby suppressing homologous recombination-mediated DNA repair and promoting tumorigenesis, indicative of cGAS as a novel therapeutic target for cancer (Liu et al., 2018a). This evidence concerns the gene CGAS and cancer.